|
시장보고서
상품코드
1762266
뇌종양 진단 및 치료 시장 규모, 점유율, 동향, 산업 분석 보고서 : 유형별, 제품별, 진단별, 치료별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)Brain Tumor Diagnosis and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type, Product, Diagnosis, Therapeutics, End Use, and Region - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면, 세계 뇌종양 진단 및 치료 시장 규모는 2034년까지 65억 972만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 상세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
뇌종양 진단 및 치료 시장은 뇌의 종양 성장을 식별하고 치료하기 위한 의료 기술 및 의학적 개입의 개발 및 개발을 중심으로 이루어지고 있습니다. 이 시장을 주도하는 것은 양성부터 악성까지 다양한 뇌종양으로 인한 복잡한 진단 및 치료 문제를 해결해야 하는 필요성입니다. 환자의 예후와 삶의 질을 개선하기 위해서는 첨단 영상 진단 기술, 정교한 임상 검사 진단, 혁신적인 치료법을 통합한 다각적인 접근이 필요합니다. 이 시장에는 신경 영상 진단 장비, 분자진단 도구, 수술 장비, 방사선 치료 시스템, 약물 치료 등 환자와 의료진의 다양한 요구를 반영하는 다양한 제품과 서비스가 포함되어 있습니다.
이 시장을 분석하면 급속한 기술 발전과 진화하는 치료 패러다임이 특징인 상황을 알 수 있습니다. 뇌종양 유병률의 증가는 노인 인구의 증가와 함께 큰 시장 촉진요인으로 작용하고 있습니다. 현재 진행 중인 연구개발은 진단 정확도 향상, 표적 치료제 개발, 환자 생존율 향상에 초점을 맞추고 있습니다. 유전체학 및 단백질체학의 발전에 힘입어 맞춤형 의료 접근법의 채택은 치료 전략에 변화를 가져오고 있습니다. 또한, 영상 진단 및 데이터 분석에 인공지능과 머신러닝을 통합하여 임상적 의사결정의 효율성과 정확성을 높이고 있습니다. 뇌종양 진단 및 치료 시장은 이러한 과제를 해결하기 위한 혁신적인 솔루션의 끊임없는 추구로 지속적인 성장이 예상됩니다.
뇌종양 진단 및 치료 시장 보고서 하이라이트
유형별로는 신경교종이나 수막종과 같은 종양의 발생률이 높고 광범위한 진단 및 치료 개입이 필요한 일차 세분화가 가장 큰 시장 점유율을 차지하고 있습니다.
제품별로는 뇌종양 진단 및 분류에 필수적인 조직학적 및 면역조직화학적 절차에서 중요한 역할을 하는 스테인 및 바니시 부문이 가장 큰 시장 점유율을 차지하고 있습니다.
진단별로는 MRI 분야가 시장을 주도하고 있습니다. 이는 비침습적 특성과 뛰어난 고해상도 영상 처리 능력으로 인해 종양의 정확한 위치 파악 및 특성화에 필수적입니다.
치료별로는 수술이 가장 큰 시장 점유율을 유지하고 있는데, 이는 종양 절제술의 기본 역할, 특히 접근이 용이하고 경계가 명확한 종양에 대한 기본적인 개입 전략에 기인합니다.
최종 용도별로는 병원 부문이 가장 큰 시장 점유율을 차지하고 있습니다. 이는 병원이 종합적인 진료를 제공하고 한 지붕 아래에서 다양한 진단 및 치료 서비스를 포괄하고 있기 때문에 일차 진료의 제공자가 되기 때문입니다.
지역별로는 북미가 세계 시장에서 가장 큰 점유율을 차지하고 있는데, 이는 의료 인프라가 잘 갖추어져 있고 뇌종양 유병률이 높기 때문입니다. 아시아태평양은 노인 인구 증가, 뇌종양에 대한 인식 증가, 의료 접근성 향상으로 인해 가장 높은 성장률을 보이고 있습니다.
주요 기업으로는 Hoffmann-La Roche AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Bristol Myers Squibb Company, Siemens Healthineers AG, GE Healthcare (General Electric Company), Canon Medical Systems Corporation, Carl Zeiss Meditec AG, Intuitive Surgical, Inc., Hitachi, Ltd. 등이 있습니다.
목차
제1장 소개
제2장 주요 요약
제3장 조사 방법
제4장 세계의 뇌종양 진단 및 치료 시장 인사이트
- 주파수 현황
- 뇌종양 진단 및 치료 시장 역학
- 성장 촉진요인과 기회
- 신경 영상 기술의 진보
- 뇌종양 증가와 인구 고령화
- 성장 억제요인과 과제
- 조기 발견의 어려움
- 성장 촉진요인과 기회
- PESTEL 분석
- 뇌종양 진단 및 치료 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 뇌종양 진단 및 치료 시장 : 유형별
- 주요 조사 결과
- 소개
- 1차
- 2차
제6장 세계의 뇌종양 진단 및 치료 시장 : 제품별
- 주요 조사 결과
- 소개
- 스테인과 바니시
- 쉘락
- 래커
- 기타
제7장 세계의 뇌종양 진단 및 치료 시장 : 진단별
- 주요 조사 결과
- 소개
- MRI
- CT 스캔
- 조직 샘플 채취
- PET-CT 스캔
- 뇌동맥조영
- 요추 천자
- 분자 검사
- 뇌파
- 기타
제8장 세계의 뇌종양 진단 및 치료 시장 : 치료별
- 주요 조사 결과
- 소개
- 수술
- 방사선 치료
- 화학요법
- 면역요법
- 표적요법
- 기타
제9장 세계의 뇌종양 진단 및 치료 시장 : 최종 용도별
- 주요 조사 결과
- 소개
- 병원
- 종양 치료 센터
- 기타
제10장 세계의 뇌종양 진단 및 치료 시장 : 지역별
- 주요 조사 결과
- 소개
- 뇌종양 진단 및 치료 시장 평가 : 지역별, 2020-2034년
- 북미
- 북미 : 유형별, 2020-2034년
- 북미 : 제품별, 2020-2034년
- 북미 : 진단별, 2020-2034년
- 북미 : 치료별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별, 2020-2034년
- 유럽 : 제품별, 2020-2034년
- 유럽 : 진단별, 2020-2034년
- 유럽 : 치료별, 2020-2034년
- 유럽 : 최종 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별, 2020-2034년
- 아시아태평양 : 제품별, 2020-2034년
- 아시아태평양 : 진단별, 2020-2034년
- 아시아태평양 : 치료별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2020-2034년
- 중동 및 아프리카 : 제품별, 2020-2034년
- 중동 및 아프리카 : 진단별, 2020-2034년
- 중동 및 아프리카 : 치료별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별, 2020-2034년
- 라틴아메리카 : 제품별, 2020-2034년
- 라틴아메리카 : 진단별, 2020-2034년
- 라틴아메리카 : 치료별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제11장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제12장 기업 개요
- Bristol Myers Squibb Company
- Canon Medical Systems Corporation
- Carl Zeiss Meditec AG
- GE Healthcare(General Electric Company)
- Hitachi, Ltd.
- Hoffmann-La Roche AG
- Intuitive Surgical, Inc.
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Siemens Healthineers AG
The global brain tumor diagnosis and therapeutics market size is expected to reach USD 6,509.72 million by 2034, according to a new study by Polaris Market Research. The report "Brain Tumor Diagnosis and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type (Primary and Secondary), Product, Diagnosis, Therapeutics, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The brain tumor diagnosis and therapeutics market centers on the development and deployment of medical technologies and pharmaceutical interventions aimed at the identification and treatment of neoplastic growths within the brain. This market is driven by the imperative to address the complex diagnostic and therapeutic challenges posed by brain tumors, which range from benign to highly malignant. It involves a multifaceted approach, integrating advanced imaging techniques, sophisticated laboratory diagnostics, and innovative treatment modalities to improve patient outcomes and quality of life. The market encompasses a broad spectrum of products and services, including neuroimaging equipment, molecular diagnostic tools, surgical devices, radiation therapy systems, and pharmaceutical therapies, reflecting the diverse needs of patients and healthcare providers.
An analysis of this market reveals a landscape characterized by rapid technological advancements and evolving treatment paradigms. The increasing prevalence of brain tumors, coupled with the growing geriatric population, is a significant market driver. Ongoing research and development efforts are focused on enhancing diagnostic accuracy, developing targeted therapies, and improving patient survival rates. The adoption of personalized medicine approaches, driven by advancements in genomics and proteomics, is transforming treatment strategies. Furthermore, the integration of artificial intelligence and machine learning in diagnostic imaging and data analysis is enhancing the efficiency and precision of clinical decision-making. The brain tumor diagnosis and therapeutics market is poised for continued growth, driven by the relentless pursuit of innovative solutions to combat these challenging diseases.
Brain Tumor Diagnosis and Therapeutics Market Report Highlights
By type, the primary segment holds the largest market share, driven by the higher incidence of tumors like gliomas and meningiomas, necessitating extensive diagnostic and therapeutic interventions.
By product, the stains & varnishes segment commands the largest market share due to its essential role in histological and immunohistochemical procedures critical for brain tumor diagnosis and classification.
Based on diagnosis, the MRI segment leads the market, attributed to its non-invasive nature and superior high-resolution imaging capabilities, crucial for precise tumor localization and characterization.
By therapeutics, the surgery segment maintains the largest market share, owing to its fundamental role in tumor removal, particularly for accessible and well-defined tumors, which remains a primary intervention strategy.
Based on end use, the hospitals segment holds the largest market share, driven by their comprehensive care offerings, encompassing a wide range of diagnostic and therapeutic services under one roof, making them primary care providers.
By region, North America holds the largest share of the global market owing to its well-established healthcare infrastructure and high prevalence of brain tumors. Asia Pacific is experiencing the highest growth rate due to the increasing geriatric population, rising awareness of brain tumors, and improving healthcare access.
Key players operating within the market include Hoffmann-La Roche AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Bristol Myers Squibb Company, Siemens Healthineers AG, GE Healthcare (General Electric Company), Canon Medical Systems Corporation, Carl Zeiss Meditec AG, Intuitive Surgical, Inc., and Hitachi, Ltd.
Polaris Market Research has segmented the brain tumor diagnosis and therapeutics market report on the basis of type, product, diagnosis, therapeutics, end use, and region:
By Type Outlook (Revenue - USD Million, 2020-2034)
Primary
Secondary
By Product Outlook (Revenue - USD Million, 2020-2034)
Stains & Varnishes
Shellacs
Lacquers
Others
By Diagnosis Outlook (Revenue - USD Million, 2020-2034)
MRI
CT Scan
Tissue Sampling
PET-CT scan
Cerebral Arteriogram
Lumbar Puncture
Molecular Testing
EEG
Others
By Therapeutics Outlook (Revenue - USD Million, 2020-2034)
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Others
By End Use Outlook (Revenue - USD Million, 2020-2034)
Hospitals
Oncology Treatment Centers
Others
By Regional Outlook (Revenue - USD Million, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Brain Tumor Diagnosis and Therapeutics Market Insights
- 4.1. Brain Tumor Diagnosis and Therapeutics Market - Frequency Snapshot
- 4.2. Brain Tumor Diagnosis and Therapeutics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Advancements in Neuroimaging Technologies
- 4.2.1.2. Increasing Prevalence of Brain Tumors and Aging Population
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Difficulty in early detection
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Brain Tumor Diagnosis and Therapeutics Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Brain Tumor Diagnosis and Therapeutics Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 5.3. Primary
- 5.3.1. Global Brain Tumor Diagnosis and Therapeutics Market, Primary, by Region, 2020-2034 (USD Million)
- 5.4. Secondary
- 5.4.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Secondary, by Region, 2020-2034 (USD Million)
6. Global Brain Tumor Diagnosis and Therapeutics Market, by Product
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 6.3. Stains & Varnishes
- 6.3.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Stains & Varnishes, by Region, 2020-2034 (USD Million)
- 6.4. Shellacs
- 6.4.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Shellacs, by Region, 2020-2034 (USD Million)
- 6.5. Lacquers
- 6.5.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Lacquers, by Region, 2020-2034 (USD Million)
- 6.6. Others
- 6.6.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Others, by Region, 2020-2034 (USD Million)
7. Global Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 7.3. MRI
- 7.3.1. Global Brain Tumor Diagnosis and Therapeutics Market, MRI, by Region, 2020-2034 (USD Million)
- 7.4. CT Scan
- 7.4.1. Global Brain Tumor Diagnosis and Therapeutics Market, CT Scan, by Region, 2020-2034 (USD Million)
- 7.5. Tissue Sampling
- 7.5.1. Global Brain Tumor Diagnosis and Therapeutics Market, Tissue Sampling, by Region, 2020-2034 (USD Million)
- 7.6. PET-CT scan
- 7.6.1. Global Brain Tumor Diagnosis and Therapeutics Market, PET-CT scan, by Region, 2020-2034 (USD Million)
- 7.7. Cerebral Arteriogram
- 7.7.1. Global Brain Tumor Diagnosis and Therapeutics Market, Cerebral Arteriogram, by Region, 2020-2034 (USD Million)
- 7.8. Lumbar Puncture
- 7.8.1. Global Brain Tumor Diagnosis and Therapeutics Market, Lumbar Puncture, by Region, 2020-2034 (USD Million)
- 7.9. Molecular Testing
- 7.9.1. Global Brain Tumor Diagnosis and Therapeutics Market, Molecular Testing, by Region, 2020-2034 (USD Million)
- 7.10. EEG
- 7.10.1. Global Brain Tumor Diagnosis and Therapeutics Market, EEG, by Region, 2020-2034 (USD Million)
- 7.11. Others
- 7.11.1. Global Brain Tumor Diagnosis and Therapeutics Market, Others, by Region, 2020-2034 (USD Million)
8. Global Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 8.3. Surgery
- 8.3.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Surgery, by Region, 2020-2034 (USD Million)
- 8.4. Radiation Therapy
- 8.4.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Radiation Therapy, by Region, 2020-2034 (USD Million)
- 8.5. Chemotherapy
- 8.5.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Chemotherapy, by Region, 2020-2034 (USD Million)
- 8.6. Immunotherapy
- 8.6.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Immunotherapy, by Region, 2020-2034 (USD Million)
- 8.7. Targeted Therapy
- 8.7.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Targeted Therapy, by Region, 2020-2034 (USD Million)
- 8.8. Others
- 8.8.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Others, by Region, 2020-2034 (USD Million)
9. Global Brain Tumor Diagnosis and Therapeutics Market, by End Use
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 9.3. Hospitals
- 9.3.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Hospitals, by Region, 2020-2034 (USD Million)
- 9.4. Oncology Treatment Centers
- 9.4.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Oncology Treatment Centers, by Region, 2020-2034 (USD Million)
- 9.5. Others
- 9.5.1. Global Brain Tumor Diagnosis and Therapeutics Market, by Others, by Region, 2020-2034 (USD Million)
10. Global Brain Tumor Diagnosis and Therapeutics Market, by Geography
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. Brain Tumor Diagnosis and Therapeutics Market Assessment, By Geography, 2020-2034 (USD Million)
- 10.3. Brain Tumor Diagnosis and Therapeutics Market - North America
- 10.3.1. North America: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.3.2. North America: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.3.3. North America: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.3.4. North America: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.3.5. North America: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.3.7. Brain Tumor Diagnosis and Therapeutics Market - U.S.
- 10.3.7.1. U.S.: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.3.7.2. U.S.: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.3.7.3. U.S.: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.3.7.4. U.S.: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.3.7.5. U.S.: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.3.8. Brain Tumor Diagnosis and Therapeutics Market - Canada
- 10.3.8.1. Canada: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.3.8.2. Canada: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.3.8.3. Canada: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.3.8.4. Canada: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.3.8.5. Canada: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.4. Brain Tumor Diagnosis and Therapeutics Market - Europe
- 10.4.1. Europe: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.4.2. Europe: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.4.3. Europe: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.4.4. Europe: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.4.5. Europe: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.4.6. Brain Tumor Diagnosis and Therapeutics Market - UK
- 10.4.6.1. UK: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.4.6.2. UK: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.4.6.3. UK: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.4.6.4. UK: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.4.6.5. UK: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.4.7. Brain Tumor Diagnosis and Therapeutics Market - France
- 10.4.7.1. France: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.4.7.2. France: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.4.7.3. France: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.4.7.4. France: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.4.7.5. France: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.4.8. Brain Tumor Diagnosis and Therapeutics Market - Germany
- 10.4.8.1. Germany: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.4.8.2. Germany: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.4.8.3. Germany: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.4.8.4. Germany: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.4.8.5. Germany: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.4.9. Brain Tumor Diagnosis and Therapeutics Market - Italy
- 10.4.9.1. Italy: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.4.9.2. Italy: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.4.9.3. Italy: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.4.9.4. Italy: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.4.9.5. Italy: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.4.10. Brain Tumor Diagnosis and Therapeutics Market - Spain
- 10.4.10.1. Spain: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.4.10.2. Spain: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.4.10.3. Spain: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.4.10.4. Spain: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.4.10.5. Spain: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.4.11. Brain Tumor Diagnosis and Therapeutics Market - Netherlands
- 10.4.11.1. Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.4.11.2. Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.4.11.3. Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.4.11.4. Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.4.11.5. Netherlands: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.4.12. Brain Tumor Diagnosis and Therapeutics Market - Russia
- 10.4.12.1. Russia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.4.12.2. Russia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.4.12.3. Russia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.4.12.4. Russia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.4.12.5. Russia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.4.13. Brain Tumor Diagnosis and Therapeutics Market - Rest of Europe
- 10.4.13.1. Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.4.13.2. Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.4.13.3. Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.4.13.4. Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.4.13.5. Rest of Europe: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.5. Brain Tumor Diagnosis and Therapeutics Market - Asia Pacific
- 10.5.1. Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.5.2. Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.5.3. Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.5.4. Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.5.5. Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.5.6. Brain Tumor Diagnosis and Therapeutics Market - China
- 10.5.6.1. China: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.5.6.2. China: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.5.6.3. China: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.5.6.4. China: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.5.6.5. China: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.5.7. Brain Tumor Diagnosis and Therapeutics Market - India
- 10.5.7.1. India: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.5.7.2. India: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.5.7.3. India: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.5.7.4. India: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.5.7.5. India: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.5.8. Brain Tumor Diagnosis and Therapeutics Market - Malaysia
- 10.5.8.1. Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.5.8.2. Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.5.8.3. Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.5.8.4. Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.5.8.5. Malaysia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.5.9. Brain Tumor Diagnosis and Therapeutics Market - Japan
- 10.5.9.1. Japan: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.5.9.2. Japan: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.5.9.3. Japan: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.5.9.4. Japan: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.5.9.5. Japan: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.5.10. Brain Tumor Diagnosis and Therapeutics Market - Indonesia
- 10.5.10.1. Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.5.10.2. Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.5.10.3. Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.5.10.4. Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.5.10.5. Indonesia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.5.11. Brain Tumor Diagnosis and Therapeutics Market - South Korea
- 10.5.11.1. South Korea: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.5.11.2. South Korea: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.5.11.3. South Korea: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.5.11.4. South Korea: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.5.11.5. South Korea: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.5.12. Brain Tumor Diagnosis and Therapeutics Market - Australia
- 10.5.12.1. Australia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.5.12.2. Australia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.5.12.3. Australia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.5.12.4. Australia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.5.12.5. Australia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.5.13. Brain Tumor Diagnosis and Therapeutics Market - Rest of Asia Pacific
- 10.5.13.1. Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.5.13.2. Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.5.13.3. Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.5.13.4. Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.5.13.5. Rest of Asia Pacific: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.6. Brain Tumor Diagnosis and Therapeutics Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.6.2. Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.6.3. Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.6.4. Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.6.5. Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.6.6. Brain Tumor Diagnosis and Therapeutics Market - Saudi Arabia
- 10.6.6.1. Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.6.6.2. Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.6.6.3. Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.6.6.4. Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.6.6.5. Saudi Arabia: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.6.7. Brain Tumor Diagnosis and Therapeutics Market - UAE
- 10.6.7.1. UAE: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.6.7.2. UAE: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.6.7.3. UAE: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.6.7.4. UAE: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.6.7.5. UAE: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.6.8. Brain Tumor Diagnosis and Therapeutics Market - Israel
- 10.6.8.1. Israel: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.6.8.2. Israel: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.6.8.3. Israel: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.6.8.4. Israel: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.6.8.5. Israel: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.6.9. Brain Tumor Diagnosis and Therapeutics Market - South Africa
- 10.6.9.1. South Africa: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.6.9.2. South Africa: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.6.9.3. South Africa: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.6.9.4. South Africa: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.6.9.5. South Africa: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.6.10. Brain Tumor Diagnosis and Therapeutics Market - Rest of Middle East & Africa
- 10.6.10.1. Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.6.10.2. Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.6.10.3. Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.6.10.4. Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.6.10.5. Rest of Middle East & Africa: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.7. Brain Tumor Diagnosis and Therapeutics Market - Latin America
- 10.7.1. Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.7.2. Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.7.3. Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.7.4. Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.7.5. Latin America: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.7.6. Brain Tumor Diagnosis and Therapeutics Market - Mexico
- 10.7.6.1. Mexico: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.7.6.2. Mexico: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.7.6.3. Mexico: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.7.6.4. Mexico: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.7.6.5. Mexico: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.7.7. Brain Tumor Diagnosis and Therapeutics Market - Brazil
- 10.7.7.1. Brazil: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.7.7.2. Brazil: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.7.7.3. Brazil: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.7.7.4. Brazil: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.7.7.5. Brazil: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.7.8. Brain Tumor Diagnosis and Therapeutics Market - Argentina
- 10.7.8.1. Argentina: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.7.8.2. Argentina: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.7.8.3. Argentina: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.7.8.4. Argentina: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.7.8.5. Argentina: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
- 10.7.9. Brain Tumor Diagnosis and Therapeutics Market - Rest of Latin America
- 10.7.9.1. Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Type, 2020-2034 (USD Million)
- 10.7.9.2. Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Product, 2020-2034 (USD Million)
- 10.7.9.3. Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Diagnosis, 2020-2034 (USD Million)
- 10.7.9.4. Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by Therapeutics, 2020-2034 (USD Million)
- 10.7.9.5. Rest of Latin America: Brain Tumor Diagnosis and Therapeutics Market, by End Use, 2020-2034 (USD Million)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. Bristol Myers Squibb Company
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Canon Medical Systems Corporation
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Carl Zeiss Meditec AG
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. GE Healthcare (General Electric Company)
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. Hitachi, Ltd.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Hoffmann-La Roche AG
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. Intuitive Surgical, Inc.
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. Merck & Co., Inc.
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Novartis AG
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Pfizer Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. Siemens Healthineers AG
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
샘플 요청 목록